2025, Number 4
<< Back Next >>
Cir Plast 2025; 35 (4)
Skin that saves. Advances and challenges in the use of cadaveric grafts in burned patients
Romero-Argüello ÓA, Franco-Tormo MJ, Ascencio-Reyes JM, Miranda-Altamirano RA, González-Aboytes JE
Language: Spanish
References: 20
Page: 214-219
PDF size: 2488.96 Kb.
ABSTRACT
Burns are a global public health problem. Early excision of necrotic tissue within the first 24 to 48 hours after injury has significantly reduced mortality in severe burn cases. Autologous skin grafting remains the gold standard for definitive closure of full-thickness burns. However, in cases involving more than 30% of total body surface area, cadaveric skin grafting is an ideal alternative. One of the main challenges in this context is immunocompatibility; therefore, it is crucial to establish standardized and controlled management of allogeneic tissues to minimize the risk of rejection and optimize clinical efficacy. This article reviews the main indications, advantages, disadvantages and clinical outcomes, supported by scientific evidence concerning the use of cadaverous skin.
REFERENCES
Fonseca CM. Aloinjertos cutáneos. Rev Cir 2025; 77 (2): 235-243.
Khoo TL, Halim AS, Saad AZ, Dorai AA. The application of glycerol-preserved skin allograft in the treatment of burn injuries: An analysis based on indications. Burns 2010; 36 (6): 897-904.
van Baare J, Ligtvoet EE, Middelkoop E. Microbiological evaluation of glycerolized cadaveric donor skin. Transplantation 1998; 65 (7): 966-970.
Richters CD, Hoekstra MJ, du Pont JS, Kreis RW, Kamperdijk EWA. Immunology of skin transplantation. Clin Dermatol 2005; 23 (4): 338-342.
Reyes Frías ML, González Villavicencio C, Salinas Anastacio MP. Apósitos de piel de cerdo preservados en glicerol. México: Banco de Tejidos Radioesterilizados, Instituto Nacional de Investigaciones Nucleares; 2007. Reporte No. 4.
Benichou G, Yamada Y, Yun SH, Lin C, Fray M, Tocco G. Immune recognition and rejection of allogeneic skin grafts. Immunotherapy 2011; 3 (6): 757-770.
Richters CD, Hoekstra MJ, van Baare J, du Pont JS, Kamperdijk EW. Immunogenicity of glycerol-preserved human cadaver skin in vitro. J Burn Care Rehabil 1997; 18 (3): 228-233.
Verbeken G, Verween G, De Vos D, Pascual B, De Corte P, Richters C et al. Glycerol treatment as recovery procedure for cryopreserved human skin allografts positive for bacteria and fungi. Cell Tissue Bank 2012; 13 (1): 1-7.
Yassaghi Y, Nazerian Y, Niazi F, Niknejad H. Advancements in cell-based therapies for thermal burn wounds: a comprehensive systematic review of clinical trials outcomes. Stem Cell Res Ther 2024; 15 (1): 277.
Sheridan R. Closure of the excised burn wound: autografts, semipermanent skin substitutes, and permanent skin substitutes. Clin Plast Surg 2009; 36(4): 643-351.
Saegeman VSM, Ectors NL, Lismont D, Verduyckt B, Verhaegen J. Short- and long-term bacterial inhibiting effect of high concentrations of glycerol used in the preservation of skin allografts. Burns 2008; 34 (2): 205-211.
Lenz M, Allorto N, Chamania S, Schiestl C, Mohr C, Boettcher M et al. Availability, effectiveness and safety of cadaveric and fresh allogeneic skin grafts in pediatric burn care—a review. Cell Tissue Bank 2025; 26 (2): 16.
Gacto-Sanchez P. Surgical treatment and management of the severely burn patient: Review and update. Med Intensiva 2017; 41 (6): 356-364.
Olivera Whyte LM, Izquierdo ME, Gutiérrez Pachón DM, Rodríguez JA, Prezzavento GE. Versatility in the use of cadaveric skin grafts for wound management. Wounds Compend Clin Res Pract 2024; 36 (9): 303-311.
World Health Organization. Burns [Internet]. Geneva: WHO; 2023. Available in: https://www.who.int/news-room/fact-sheets/detail/burns
Válik A, Harangozó K, Garami A, Juhász Z, Józsa G, Lorincz A. Mid-term follow-up study of children undergoing autologous skin transplantation for burns. Life 2023; 13 (3): 762.
Braza ME, Marietta M, Fahrenkopf MP. Split-thickness skin grafts. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. Available in: http://www.ncbi.nlm.nih.gov/books/NBK551561/
Vecin NM, Kirsner RS. Skin substitutes as treatment for chronic wounds: current and future directions. Front Med 2023; 10: 1154567.
Obeng MK, McCauley RL, Barnett JR, Heggers JP, Sheridan K, Schutzler SS. Cadaveric allograft discards as a result of positive skin cultures. Burns J Int Soc Burn Inj 2001; 27 (3): 267-271.
Iyun AO, Ademola SA, Olawoye OA, Michael AI, Aderibigbe RO, Iyun OI et al. Glycerolised skin allografts for extensive burns in low- and middle-income countries. J West Afr Coll Surg 2021; 11 (3): 35-41.